LPS receptor subunits have antagonistic roles in epithelial apoptosis and colonic carcinogenesis

Cell Death and Differentiation

Volumn 22, Issue 10, 2015, Pages 1590-1604

  Kuo, W T ^a   Lee, T C ^a   Yang, H Y ^a   Chen, C Y ^a   Au, Y C ^a   Lu, Y Z ^a   Wu, L L ^a   Wei, S C ^a   Ni, Y H ^a   Lin, B R ^b   Chen, Y ^c,d   Tsai, Y H ^c,d   Kung, J T ^e   Sheu, F ^b   Lin, L W ^f   Yu, L C H ^a  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^d YUAN ZE UNIVERSITY   (Taiwan)

^e INSTITUTE OF MOLECULAR BIOLOGY   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; LIPOPOLYSACCHARIDE; PHOSPHATIDYLCHOLINE; PHOSPHOLIPASE C; PROTEIN KINASE C ZETA; RECEPTOR SUBUNIT; SPHINGOMYELIN PHOSPHODIESTERASE; TOLL LIKE RECEPTOR 4;

APOPTOSIS; ARTICLE; CACO 2 CELL LINE; CANCER TISSUE; CELL DEATH; CELL SURVIVAL; COLON CARCINOGENESIS; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; EPITHELIUM CELL; GENE SILENCING; HUMAN; HUMAN CELL; IN VITRO STUDY; MUCOSA; MUTANT; PRIORITY JOURNAL; WILD TYPE; ANIMAL; CACO-2 CELL LINE; CARCINOGENESIS; COLON; COLORECTAL TUMOR; GENETICS; METABOLISM; MOUSE; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ANTIGENS, CD14; APOPTOSIS; CACO-2 CELLS; CARCINOGENESIS; COLON; COLORECTAL NEOPLASMS; EPITHELIAL CELLS; HUMANS; MICE; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 4;

EID: 84941173166     PISSN: 13509047     EISSN: 14765403     Source Type: Journal    
DOI: 10.1038/cdd.2014.240     Document Type: Article

References (64)

1. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell 2011; 144: 646-674.
2. Bedi A, Pasricha PJ, Akhtar AJ, Barber JP, Bedi GC, Giardiello FM et al. Inhibition of apoptosis during development of colorectal cancer. Cancer Res 1995; 55: 1811-1816.
3. Miura K, Fujibuchi W, Ishida K, Naitoh T, Ogawa H, Ando T et al. Inhibitor of apoptosis protein family as diagnostic markers and therapeutic targets of colorectal cancer. Surg Today 2011; 41: 175-182.
4. Shanmugathasan M, Jothy S. Apoptosis, anoikis and their relevance to the pathobiology of colon cancer. Pathol Int 2000; 50: 273-279.
5. Greten FR, Eckmann L, Greten TF, Park JM, Li ZW, Egan LJ et al. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004; 118: 285-296.
6. Hu Y, Le Leu RK, Young GP. Absence of acute apoptotic response to genotoxic carcinogens in p53-deficient mice is associated with increased susceptibility to azoxymethane-induced colon tumours. Int J Cancer. 2005; 115: 561-567.
7. Duckworth CA, Pritchard DM. Suppression of apoptosis, crypt hyperplasia, and altered differentiation in the colonic epithelia of bak-null mice. Gastroenterology 2009; 136: 943-952.
8. Liu F, Bardhan K, Yang D, Thangaraju M, Ganapathy V, Waller JL et al. NF-kappaB directly regulates Fas transcription to modulate Fas-mediated apoptosis and tumor suppression. J Biol Chem 2012; 287: 25530-25540.
9. Yu LC, Wang JT, Wei SC, Ni YH. Host-microbial interactions and regulation of intestinal epithelial barrier function: from physiology to pathology. World J Gastrointest Pathophysiol 2012; 3: 27-43.
10. Edelblum KL, Yan F, Yamaoka T, Polk DB. Regulation of apoptosis during homeostasis and disease in the intestinal epithelium. Inflamm Bowel Dis 2006; 12: 413-424.
11. Shirkey TW, Siggers RH, Goldade BG, Marshall JK, Drew MD, Laarveld B et al. Effects of commensal bacteria on intestinal morphology and expression of proinflammatory cytokines in the gnotobiotic pig. Exp Biol Med (Maywood) 2006; 231: 1333-1345.
12. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 2004; 118: 229-241.
13. Scharl M, Rogler G. Microbial sensing by the intestinal epithelium in the pathogenesis of inflammatory bowel disease. Int J Inflamm 2010; 2010: 671258.
14. Rakoff-Nahoum S, Medzhitov R. Role of toll-like receptors in tissue repair and tumorigenesis. Biochem Biokhimiia 2008; 73: 555-561.
15. Abreu MT. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function. Nat Rev Immunol 2010; 10: 131-144.
16. Martin-Villa JM, Ferre-Lopez S, Lopez-Suarez JC, Corell A, Perez-Blas M, Arnaiz-Villena A. Cell surface phenotype and ultramicroscopic analysis of purified human enterocytes: a possible antigen-presenting cell in the intestine. Tissue Antigens 1997; 50: 586-592.
17. Belmonte L, Beutheu Youmba S, Bertiaux-Vandaele N, Antonietti M, Lecleire S, Zalar A et al. Role of toll like receptors in irritable bowel syndrome: differential mucosal immune activation according to the disease subtype. PLoS One 2012; 7: e42777.
18. Wang EL, Qian ZR, Nakasono M, Tanahashi T, Yoshimoto K, Bando Y et al. High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer. Brit J Cancer 2010; 102: 908-915.
19. Fukata M, Chen A, Vamadevan AS, Cohen J, Breglio K, Krishnareddy S et al. Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology 2007; 133: 1869-1881.
20. Yu LC, Flynn AN, Turner JR, Buret AG. SGLT-1-mediated glucose uptake protects intestinal epithelial cells against LPS-induced apoptosis and barrier defects: a novel cellular rescue mechanism? FASEB J 2005; 19: 1822-1835.
21. Chin AC, Flynn AN, Fedwick JP, Buret AG. The role of caspase-3 in lipopolysaccharide-mediated disruption of intestinal epithelial tight junctions. Can J Physiol Pharmacol 2006; 84: 1043-1050.
22. Ruemmele FM, Beaulieu JF, Dionne S, Levy E, Seidman EG, Cerf-Bensussan N et al. Lipopolysaccharide modulation of normal enterocyte turnover by toll-like receptors is mediated by endogenously produced tumour necrosis factor alpha. Gut 2002; 51: 842-848.
23. Grondin V, Seksik P, Dumont S, Thomas G, Trugnan G, Flejou JF et al. Regulation of colon cancer cell proliferation and migration by MD-2 activity. Innate Immun 2011; 17: 414-422.
24. da Silva Correia J, Soldau K, Christen U, Tobias PS, Ulevitch RJ. Lipopolysaccharide is in close proximity to each of the proteins in its membrane receptor complex. transfer from CD14 to TLR4 and MD-2. J Biol Chem 2001; 276: 21129-21135.
25. Dunzendorfer S, Lee HK, Soldau K, Tobias PS. TLR4 is the signaling but not the lipopolysaccharide uptake receptor. J Immunol 2004; 173: 1166-1170.
26. Cuschieri J, Billgren J, Maier RV. Phosphatidylcholine-specific phospholipase C (PC-PLC) is required for LPS-mediated macrophage activation through CD14. J Leukoc Biol 2006; 80: 407-414.
27. Triantafilou M, Miyake K, Golenbock DT, Triantafilou K. Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J Cell Sci 2002; 115: 2603-2611.
28. Colell A, Morales A, Fernandez-Checa JC, Garcia-Ruiz C. Ceramide generated by acidic sphingomyelinase contributes to tumor necrosis factor-alpha-mediated apoptosis in human colon HT-29 cells through glycosphingolipids formation. Possible role of ganglioside GD3. FEBS Lett 2002; 526: 135-141.
29. Kim M, Datta A, Brakeman P, Yu W, Mostov KE. Polarity proteins PAR6 and aPKC regulate cell death through GSK-3beta in 3D epithelial morphogenesis. J Cell Sci 2007; 120: 2309-2317.
30. Garcia-Barros M, Coant N, Truman JP, Snider AJ, Hannun YA. Sphingolipids in colon cancer. Biochim Biophys Acta 2014; 1841: 773-782.
31. Hertervig E, Nilsson A, Nilbert M, Duan RD. Reduction in alkaline sphingomyelinase in colorectal tumorigenesis is not related to the APC gene mutation. Int J Colorectal Dis 2003; 18: 309-313.
32. Ma L, Tao Y, Duran A, Llado V, Galvez A, Barger JF et al. Control of nutrient stress-induced metabolic reprogramming by PKCzeta in tumorigenesis. Cell 2013; 152: 599-611.
33. Nenci A, Becker C, Wullaert A, Gareus R, van Loo G, Danese S et al. Epithelial NEMO links innate immunity to chronic intestinal inflammation. Nature 2007; 446: 557-561.
34. Edelblum KL, Washington MK, Koyama T, Robine S, Baccarini M, Polk DB. Raf protects against colitis by promoting mouse colon epithelial cell survival through NF-kappaB. Gastroenterology 2008; 135: 539-551.
35. Fukata M, Chen A, Klepper A, Krishnareddy S, Vamadevan AS, Thomas LS et al. Cox-2 is regulated by Toll-like receptor-4 (TLR4) signaling: role in proliferation and apoptosis in the intestine. Gastroenterology 2006; 131: 862-877.
36. Rakoff-Nahoum S, Medzhitov R. Regulation of spontaneous intestinal tumorigenesis through the adaptor protein MyD88. Science 2007; 317: 124-127.
37. Nambiar PR, Girnun G, Lillo NA, Guda K, Whiteley HE, Rosenberg DW. Preliminary analysis of azoxymethane induced colon tumors in inbred mice commonly used as transgenic/knockout progenitors. Int J Oncol. 2003; 22: 145-150.
38. Nagamine CM, Rogers AB, Fox JG, Schauer DB. Helicobacter hepaticus promotes azoxymethane-initiated colon tumorigenesis in BALB/c-IL10-deficient mice. Int J Cancer 2008; 122: 832-838.
39. Kim HM, Park BS, Kim JI, Kim SE, Lee J, Oh SC et al. Crystal structure of the TLR4-MD-2 complex with bound endotoxin antagonist Eritoran. Cell 2007; 130: 906-917.
40. Yeh YC, Ko WJ, Chan KC, Fan SZ, Tsai JC, Cheng YJ et al. Effects of eritoran tetrasodium, a Toll-like receptor 4 antagonist, on intestinal microcirculation in endotoxemic rats. Shock 2012; 37: 556-561.
41. Araki Y, Sugihara H, Hattori T. In vitro effects of dextran sulfate sodium on a Caco-2 cell line and plausible mechanisms for dextran sulfate sodium-induced colitis. Oncol Rep 2006; 16: 1357-1362.
42. Chen R, Luo FK, Wang YL, Tang JL, Liu YS. LBP and CD14 polymorphisms correlate with increased colorectal carcinoma risk in Han Chinese. World J Gastroenterol 2011; 17: 2326-2331.
43. Eyking A, Ey B, Runzi M, Roig AI, Reis H, Schmid KW et al. Toll-like receptor 4 variant D299G induces features of neoplastic progression in Caco-2 intestinal cells and is associated with advanced human colon cancer. Gastroenterology 2011; 141: 2154-2165.
44. Pimentel-Nunes P, Teixeira AL, Pereira C, Gomes M, Brandao C, Rodrigues C et al. Functional polymorphisms of Toll-like receptors 2 and 4 alter the risk for colorectal carcinoma in Europeans. Dig Liver Dis 2013; 45: 63-69.
45. Fukata M, Shang L, Santaolalla R, Sotolongo J, Pastorini C, Espana C et al. Constitutive activation of epithelial TLR4 augments inflammatory responses to mucosal injury and drives colitis-associated tumorigenesis. Inflamm Bowel Dis 2011; 17: 1464-1473.
46. Santaolalla R, Sussman DA, Ruiz JR, Davies JM, Pastorini C, Espana CL et al. TLR4 activates the beta-catenin pathway to cause intestinal neoplasia. PLoS One 2013; 8: e63298.
47. Carpenter S, O'Neill LA. Recent insights into the structure of Toll-like receptors and post-translational modifications of their associated signalling proteins. Biochem J 2009; 422: 1-10.
48. Czerkies M, Borzecka K, Zdioruk MI, Plociennikowska A, Sobota A, Kwiatkowska K. An interplay between scavenger receptor A and CD14 during activation of J774 cells by high concentrations of LPS. Immunobiology 2013; 218: 1217-1226.
49. Cario E, Rosenberg IM, Brandwein SL, Beck PL, Reinecker HC, Podolsky DK. Lipopolysaccharide activates distinct signaling pathways in intestinal epithelial cell lines expressing Toll-like receptors. J Immunol 2000; 164: 966-972.
50. Abreu MT, Vora P, Faure E, Thomas LS, Arnold ET, Arditi M. Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J Immunol 2001; 167: 1609-1616.
51. Suzuki M, Hisamatsu T, Podolsky DK. Gamma interferon augments the intracellular pathway for lipopolysaccharide (LPS) recognition in human intestinal epithelial cells through coordinated up-regulation of LPS uptake and expression of the intracellular Toll-like receptor 4-MD-2 complex. Infect Immun 2003; 71: 3503-3511.
52. Yagi S, Takaki A, Hori T, Sugimura K. Enteric lipopolysaccharide raises plasma IL-6 levels in the hepatoportal vein during noninflammatory stress in the rat. Fukuoka Acta Med 2002; 93: 38-52.
53. Zanoni I, Ostuni R, Capuano G, Collini M, Caccia M, Ronchi AE et al. CD14 regulates the dendritic cell life cycle after LPS exposure through NFATactivation. Nature 2009; 460: 264-268.
54. Dobrovolskaia MA, Vogel SN. Toll receptors, CD14, and macrophage activation and deactivation by LPS. Microbes Infect 2002; 4: 903-914.
55. Hsu LC, Park JM, Zhang K, Luo JL, Maeda S, Kaufman RJ et al. The protein kinase PKR is required for macrophage apoptosis after activation of Toll-like receptor 4. Nature 2004; 428: 341-345.
56. Rallabhandi P, Bell J, Boukhvalova MS, Medvedev A, Lorenz E, Arditi M et al. Analysis of TLR4 polymorphic variants: new insights into TLR4/MD-2/CD14 stoichiometry, structure, and signaling. J Immunol 2006; 177: 322-332.
57. Wang EL, Qian ZR, Nakasono M, Tanahashi T, Yoshimoto K, Bando Y et al. High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer. Br J Cancer 2010; 102: 908-915.
58. Uronis JM, Muhlbauer M, Herfarth HH, Rubinas TC, Jones GS, Jobin C. Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility. PLoS One 2009; 4: e6026.
59. Wu LL, Chiu HD, Peng WH, Lin BR, Lu KS, Lu YZ et al. Epithelial inducible nitric oxide synthase causes bacterial translocation by impairment of enterocytic tight junctions via intracellular signals of Rho-associated kinase and protein kinase C zeta. Crit Care Med 2011; 39: 2087-2098.
60. Huang CY, Hsiao JK, Lu YZ, Lee TC, Yu LC. Anti-apoptotic PI3K/Akt signaling by sodium/glucose transporter 1 reduces epithelial barrier damage and bacterial translocation in intestinal ischemia. Lab Invest 2011; 91: 294-309.
61. Yu LC, Turner JR, Buret AG. LPS/CD14 activation triggers SGLT-1-mediated glucose uptake and cell rescue in intestinal epithelial cells via early apoptotic signals upstream of caspase-3. Exp Cell Res 2006; 312: 3276-3286.
62. Chen J, Winston JH, Sarna SK. Neurological and cellular regulation of visceral hypersensitivity induced by chronic stress and colonic inflammation in rats. Neuroscience 2013; 248C: 469-478.
63. Sato T, Stange DE, Ferrante M, Vries RG, Van Es JH, Van den Brink S et al. Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium. Gastroenterology 2011; 141: 1762-1772.
64. Huang CY, Kuo WT, Huang YC, Lee TC, Yu LC. Resistance to hypoxia-induced necroptosis is conferred by glycolytic pyruvate scavenging of mitochondrial superoxide in colorectal cancer cells. Cell Death Dis 2013; 4: e622.